[Exercise test in the evaluation of the efficacy of drug therapy].
Febo
O
O
Divisione di Cardiologia, Fondazione Salvatore Maugeri, IRCCS, Montescano.
Cobelli
F
F
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003846:Deoxyepinephrine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004070:Digitalis; D005069:Evaluation Studies as Topic; D005080:Exercise Test; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D010101:Oxygen Consumption; D010946:Plants, Medicinal; D010947:Plants, Toxic; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*; D017307:Xamoterol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D000804:Angiotensin II; D017307:Xamoterol; C023487:ibopamine; D003846:Deoxyepinephrine